Monitoring abnormal laboratory values as antecedents to drug-induced injury

Sandra L. Kane-Gill, Joseph F. Dasta, Philip J Schneider, Charles H. Cook

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Background: Clinical abnormalities associated with drug therapy may lead to injury if untreated. Detection of preceding drug-related hazardous conditions (DRHCs) may provide the opportunity to prevent injury. This study evaluated the frequency of abnormal laboratory values attributed to the effect of drugs. Methods: A total of 590 patients consecutively admitted to a surgical intensive care unit during a 3-month period were prospectively studied. Serum electrolyte, platelet, creatinine, glucose, magnesium, and liver enzyme concentrations were classified as either normal or abnormal using standard criteria. DRHCs were abnormal laboratory results determined to be caused by drugs. Results: DRHCs were detected in 16.4% of patients, reflecting a rate of 47 events per 1,000 patient days. 66%, 22%, and 12% of DRHCs were categorized as either definite, probable, or possible, respectively. In 97% of suspected DRHCs, clinicians responded by ordering additional laboratory tests or changing drug regimens. Conclusions: Monitoring laboratory values and assessing the association to medications may reduce the risk of injury consequent to adverse drug events.

Original languageEnglish (US)
Pages (from-to)1457-1462
Number of pages6
JournalJournal of Trauma
Volume59
Issue number6
DOIs
StatePublished - Dec 2005
Externally publishedYes

Fingerprint

Wounds and Injuries
Pharmaceutical Preparations
Critical Care
Drug-Related Side Effects and Adverse Reactions
Magnesium
Electrolytes
Intensive Care Units
Creatinine
Blood Platelets
Glucose
Drug Therapy
Liver
Enzymes
Serum

Keywords

  • Adverse drug events
  • Critically ill
  • Drug-related hazardous conditions
  • Intensive care unit
  • Patient safety

ASJC Scopus subject areas

  • Surgery

Cite this

Monitoring abnormal laboratory values as antecedents to drug-induced injury. / Kane-Gill, Sandra L.; Dasta, Joseph F.; Schneider, Philip J; Cook, Charles H.

In: Journal of Trauma, Vol. 59, No. 6, 12.2005, p. 1457-1462.

Research output: Contribution to journalArticle

Kane-Gill, Sandra L. ; Dasta, Joseph F. ; Schneider, Philip J ; Cook, Charles H. / Monitoring abnormal laboratory values as antecedents to drug-induced injury. In: Journal of Trauma. 2005 ; Vol. 59, No. 6. pp. 1457-1462.
@article{d962f5e0d81d443b964117692d5abb73,
title = "Monitoring abnormal laboratory values as antecedents to drug-induced injury",
abstract = "Background: Clinical abnormalities associated with drug therapy may lead to injury if untreated. Detection of preceding drug-related hazardous conditions (DRHCs) may provide the opportunity to prevent injury. This study evaluated the frequency of abnormal laboratory values attributed to the effect of drugs. Methods: A total of 590 patients consecutively admitted to a surgical intensive care unit during a 3-month period were prospectively studied. Serum electrolyte, platelet, creatinine, glucose, magnesium, and liver enzyme concentrations were classified as either normal or abnormal using standard criteria. DRHCs were abnormal laboratory results determined to be caused by drugs. Results: DRHCs were detected in 16.4{\%} of patients, reflecting a rate of 47 events per 1,000 patient days. 66{\%}, 22{\%}, and 12{\%} of DRHCs were categorized as either definite, probable, or possible, respectively. In 97{\%} of suspected DRHCs, clinicians responded by ordering additional laboratory tests or changing drug regimens. Conclusions: Monitoring laboratory values and assessing the association to medications may reduce the risk of injury consequent to adverse drug events.",
keywords = "Adverse drug events, Critically ill, Drug-related hazardous conditions, Intensive care unit, Patient safety",
author = "Kane-Gill, {Sandra L.} and Dasta, {Joseph F.} and Schneider, {Philip J} and Cook, {Charles H.}",
year = "2005",
month = "12",
doi = "10.1097/01.ta.0000196009.42623.50",
language = "English (US)",
volume = "59",
pages = "1457--1462",
journal = "Journal of Trauma and Acute Care Surgery",
issn = "2163-0755",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Monitoring abnormal laboratory values as antecedents to drug-induced injury

AU - Kane-Gill, Sandra L.

AU - Dasta, Joseph F.

AU - Schneider, Philip J

AU - Cook, Charles H.

PY - 2005/12

Y1 - 2005/12

N2 - Background: Clinical abnormalities associated with drug therapy may lead to injury if untreated. Detection of preceding drug-related hazardous conditions (DRHCs) may provide the opportunity to prevent injury. This study evaluated the frequency of abnormal laboratory values attributed to the effect of drugs. Methods: A total of 590 patients consecutively admitted to a surgical intensive care unit during a 3-month period were prospectively studied. Serum electrolyte, platelet, creatinine, glucose, magnesium, and liver enzyme concentrations were classified as either normal or abnormal using standard criteria. DRHCs were abnormal laboratory results determined to be caused by drugs. Results: DRHCs were detected in 16.4% of patients, reflecting a rate of 47 events per 1,000 patient days. 66%, 22%, and 12% of DRHCs were categorized as either definite, probable, or possible, respectively. In 97% of suspected DRHCs, clinicians responded by ordering additional laboratory tests or changing drug regimens. Conclusions: Monitoring laboratory values and assessing the association to medications may reduce the risk of injury consequent to adverse drug events.

AB - Background: Clinical abnormalities associated with drug therapy may lead to injury if untreated. Detection of preceding drug-related hazardous conditions (DRHCs) may provide the opportunity to prevent injury. This study evaluated the frequency of abnormal laboratory values attributed to the effect of drugs. Methods: A total of 590 patients consecutively admitted to a surgical intensive care unit during a 3-month period were prospectively studied. Serum electrolyte, platelet, creatinine, glucose, magnesium, and liver enzyme concentrations were classified as either normal or abnormal using standard criteria. DRHCs were abnormal laboratory results determined to be caused by drugs. Results: DRHCs were detected in 16.4% of patients, reflecting a rate of 47 events per 1,000 patient days. 66%, 22%, and 12% of DRHCs were categorized as either definite, probable, or possible, respectively. In 97% of suspected DRHCs, clinicians responded by ordering additional laboratory tests or changing drug regimens. Conclusions: Monitoring laboratory values and assessing the association to medications may reduce the risk of injury consequent to adverse drug events.

KW - Adverse drug events

KW - Critically ill

KW - Drug-related hazardous conditions

KW - Intensive care unit

KW - Patient safety

UR - http://www.scopus.com/inward/record.url?scp=33646190678&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646190678&partnerID=8YFLogxK

U2 - 10.1097/01.ta.0000196009.42623.50

DO - 10.1097/01.ta.0000196009.42623.50

M3 - Article

C2 - 16394922

AN - SCOPUS:33646190678

VL - 59

SP - 1457

EP - 1462

JO - Journal of Trauma and Acute Care Surgery

JF - Journal of Trauma and Acute Care Surgery

SN - 2163-0755

IS - 6

ER -